OBJECTIVE: Because ouabain activates several pathways that are critical to cardioprotective mechanisms such as ischemic preconditioning, we tested if this digitalis compound could protect the heart against ischemia-reperfusion injury through activation of the Na+,K+-ATPase/c-Src receptor complex. METHODS AND RESULTS: In Langendorff-perfused rat hearts, a short (4 min) administration of ouabain 10 muM followed by an 8-minute washout before 30 min of global ischemia and reperfusion improved cardiac function, decreased lactate dehydrogenase release and reduced infarct size by 40%. Western blot analysis revealed that ouabain activated the cardioprotective phospholipase Cgamma1/protein kinase Cepsilon (PLC-gamma1/PKCepsilon) pathway. Pre-treatment of the hearts with the Src kinase family inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolol[3,4-d]pyrimidine (PP2) blocked not only ouabain-induced activation of PLC-gamma1/PKCepsilon pathway, but also cardiac protection. This protection was also blocked by a PKCepsilon translocation inhibitor peptide (PKCepsilon TIP). CONCLUSION: Short exposure to a low concentration of ouabain protects the heart against ischemia/reperfusion injury. This effect of ouabain on the heart is most likely due to the activation of the Na+,K+-ATPase/c-Src receptor complex and subsequent stimulation of key mediators of preconditioning, namely PLC-gamma1 and PKCepsilon.
OBJECTIVE: Because ouabain activates several pathways that are critical to cardioprotective mechanisms such as ischemic preconditioning, we tested if this digitalis compound could protect the heart against ischemia-reperfusion injury through activation of the Na+,K+-ATPase/c-Src receptor complex. METHODS AND RESULTS: In Langendorff-perfused rat hearts, a short (4 min) administration of ouabain 10 muM followed by an 8-minute washout before 30 min of global ischemia and reperfusion improved cardiac function, decreased lactate dehydrogenase release and reduced infarct size by 40%. Western blot analysis revealed that ouabain activated the cardioprotective phospholipase Cgamma1/protein kinase Cepsilon (PLC-gamma1/PKCepsilon) pathway. Pre-treatment of the hearts with the Src kinase family inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolol[3,4-d]pyrimidine (PP2) blocked not only ouabain-induced activation of PLC-gamma1/PKCepsilon pathway, but also cardiac protection. This protection was also blocked by a PKCepsilon translocation inhibitor peptide (PKCepsilon TIP). CONCLUSION: Short exposure to a low concentration of ouabain protects the heart against ischemia/reperfusion injury. This effect of ouabain on the heart is most likely due to the activation of the Na+,K+-ATPase/c-Src receptor complex and subsequent stimulation of key mediators of preconditioning, namely PLC-gamma1 and PKCepsilon.
Authors: Christopher P Baines; Jun Zhang; Guang-Wu Wang; Yu-Ting Zheng; Joanne X Xiu; Ernest M Cardwell; Roberto Bolli; Peipei Ping Journal: Circ Res Date: 2002-03-08 Impact factor: 17.367
Authors: Mamoru Munakata; Christof Stamm; Ingeborg Friehs; David Zurakowski; Douglas B Cowan; Hung Cao-Danh; Francis X McGowan; Pedro J del Nido Journal: Ann Thorac Surg Date: 2002-04 Impact factor: 4.330
Authors: Pierre Dos Santos; Alicia J Kowaltowski; Muriel N Laclau; Subramanian Seetharaman; Petr Paucek; Sihem Boudina; Jean-Benoit Thambo; Liliane Tariosse; Keith D Garlid Journal: Am J Physiol Heart Circ Physiol Date: 2002-07 Impact factor: 4.733
Authors: Keith D Garlid; Alexandre D T Costa; Casey L Quinlan; Sandrine V Pierre; Pierre Dos Santos Journal: J Mol Cell Cardiol Date: 2008-12-11 Impact factor: 5.000
Authors: Kobra Haghighi; Tracy Pritchard; Julie Bossuyt; Jason R Waggoner; Qunying Yuan; Guo-Chang Fan; Hanna Osinska; Ahmad Anjak; Jack Rubinstein; Jeffrey Robbins; Donald M Bers; Evangelia G Kranias Journal: J Mol Cell Cardiol Date: 2011-12-01 Impact factor: 5.000
Authors: Eric E Morgan; Zhichuan Li; Cory Stebal; Aude Belliard; Glen Tennyson; Bijan Salari; Keith D Garlid; Sandrine V Pierre Journal: J Cardiovasc Pharmacol Date: 2010-03 Impact factor: 3.105
Authors: Yan Bai; Eric E Morgan; David R Giovannucci; Sandrine V Pierre; Kenneth D Philipson; Amir Askari; Lijun Liu Journal: Am J Physiol Heart Circ Physiol Date: 2012-11-30 Impact factor: 4.733